MedPath

Comparison between the synergistic use of oral contraceptives and fluoxetine vs fluoxetine alone in the management of premenstrual syndrome

Phase 3
Recruiting
Conditions
Premenstrual syndrome
Reproductive Health and Childbirth - Menstruation and menopause
Registration Number
ACTRN12614001243606
Lead Sponsor
Cairo university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
210
Inclusion Criteria

Age 20-40 years
Premenstrual syndrome
Nulligravida

Exclusion Criteria

Diabetes
Hypertension
Liver disease
History of DVT
Allergy to fluoxetine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath